Pereira Paulo, Westgard James O, Encarnação Pedro, Seghatchian Jerard
Department of Quality Assurance, Portuguese Institute of Blood and Transplant, Avenida Miguel Bombarda 6, 1000-208 Lisboa, Portugal.
Transfus Apher Sci. 2014 Oct;51(2):126-31. doi: 10.1016/j.transci.2014.10.004.
The evaluation of measurement uncertainty is not required by the European Union regulation or blood establishments’ laboratory tests. However, it is required for tests accredited by ISO 15189. Also, the forthcoming ISO 9001 edition requires “risk based thinking” with risk described as “the effect of uncertainty on an expected result”. ISO recommends GUM models for determination of measurement uncertainty, but their application is not intended for ordinal value measurements, such as what happens with screening test binary results. This article reviews, discusses and proposes concepts intended for measurement uncertainty of screening test results. The precision model focuses on cutoff level allowing the evaluation of the indeterminate interval using analytical sources of variance. The intervalis considered in the estimation of the seroconversion window period. The delta-value of patients and healthy subjects’ samples allows ranking two tests according to the probability of the two classes of indeterminate results: chance of false negative results and chance of false positive results (waste on budget).
欧盟法规或血液机构的实验室检测并不要求对测量不确定度进行评估。然而,对于通过ISO 15189认可的检测则有此要求。此外,即将发布的ISO 9001版本要求进行“基于风险的思维”,其中风险被描述为“不确定性对预期结果的影响”。ISO推荐使用GUM模型来确定测量不确定度,但其应用并不适用于序数值测量,例如筛查试验二元结果的情况。本文回顾、讨论并提出了针对筛查试验结果测量不确定度的概念。精密度模型侧重于临界值水平,允许使用方差分析来源评估不确定区间。在估计血清转换窗口期时会考虑该区间。患者和健康受试者样本的δ值允许根据两类不确定结果的概率对两种检测进行排序:假阴性结果的概率和假阳性结果的概率(预算浪费)。